{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:51:05Z","timestamp":1774947065445,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T00:00:00Z","timestamp":1069632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1038\/ni1012","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T22:16:08Z","timestamp":1069712168000},"page":"1169-1176","source":"Crossref","is-referenced-by-count":495,"title":["Suppressors of cytokine signaling and immunity"],"prefix":"10.1038","volume":"4","author":[{"given":"Masato","family":"Kubo","sequence":"first","affiliation":[]},{"given":"Toshikatsu","family":"Hanada","sequence":"additional","affiliation":[]},{"given":"Akihiko","family":"Yoshimura","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,11,24]]},"reference":[{"key":"BFni1012_CR1","volume-title":"Guidebook to Cytokines and Their Receptors","author":"NA Nicola","year":"1994","unstructured":"Nicola, N.A. (ed.) Guidebook to Cytokines and Their Receptors (Oxford University Press, Oxford, 1994)."},{"key":"BFni1012_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/377591a0","volume":"377","author":"JN Ihle","year":"1995","unstructured":"Ihle, J.N. Cytokine receptor signalling. Nature 377, 591\u2013594 (1995).","journal-title":"Nature"},{"key":"BFni1012_CR3","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","volume":"109","author":"JJ O'Shea","year":"2002","unstructured":"O'Shea, J.J., Gadina, M. & Schreiber, R.D. Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway. Cell. 109, S121\u2013131 (2002).","journal-title":"Cell."},{"key":"BFni1012_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","volume":"18","author":"H Yasukawa","year":"2000","unstructured":"Yasukawa, H., Sasaki A. & Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18, 143\u2013164 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni1012_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nri818","volume":"2","author":"WS Alexander","year":"2002","unstructured":"Alexander, W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2, 410\u2013416 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni1012_CR6","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1053\/gast.2002.37068","volume":"123","author":"CJ Greenhalgh","year":"2002","unstructured":"Greenhalgh, C.J., Miller, M.E., Hilton, D.J. & Lund, P.K. Suppressors of cytokine signaling: relevance to gastrointestinal function and disease. Gastroenterology 123, 2064\u20132081 (2002).","journal-title":"Gastroenterology"},{"key":"BFni1012_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/43219","volume":"387","author":"T Naka","year":"1997","unstructured":"Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924\u2013929 (1997).","journal-title":"Nature"},{"key":"BFni1012_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/43206","volume":"387","author":"R Starr","year":"1997","unstructured":"Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917\u2013921 (1997).","journal-title":"Nature"},{"key":"BFni1012_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/43213","volume":"387","author":"TA Endo","year":"1997","unstructured":"Endo, T.A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921\u2013924 (1997).","journal-title":"Nature"},{"key":"BFni1012_CR10","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/j.1460-2075.1995.tb07281.x","volume":"14","author":"A Yoshimura","year":"1995","unstructured":"Yoshimura, A. et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14: 2816\u20132826 (1995).","journal-title":"EMBO J."},{"key":"BFni1012_CR11","doi-asserted-by":"publisher","first-page":"35553","DOI":"10.1074\/jbc.274.50.35553","volume":"274","author":"PA Ram","year":"1999","unstructured":"Ram, P.A. & Waxman, D.J. SOCS\/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553\u201335561 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-5793(99)00681-X","volume":"453","author":"H Favre","year":"1999","unstructured":"Favre, H., Benhamou, A., Finidori, J., Kelly, P.A. & Edery, M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett.; 453: 63\u201366 (1999).","journal-title":"FEBS Lett."},{"key":"BFni1012_CR13","doi-asserted-by":"publisher","first-page":"40181","DOI":"10.1074\/jbc.C200450200","volume":"277","author":"CJ Greenhalgh","year":"2002","unstructured":"Greenhalgh, C.J. et al. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277, 40181\u201340184 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR14","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1210\/mend.16.6.0845","volume":"16","author":"CJ Greenhalgh","year":"2002","unstructured":"Greenhalgh, C.J. et al. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 16, 1394\u20131406 (2002).","journal-title":"Mol. Endocrinol."},{"key":"BFni1012_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/35016611","volume":"405","author":"D Metcalf","year":"2000","unstructured":"Metcalf, D. et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405, 1069\u20131073 (2000).","journal-title":"Nature"},{"key":"BFni1012_CR16","doi-asserted-by":"publisher","first-page":"13003","DOI":"10.1073\/pnas.202477099","volume":"99","author":"Y Seki","year":"2002","unstructured":"Seki, Y. et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. USA 99, 13003\u201313008 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","volume":"18","author":"H Yasukawa","year":"1999","unstructured":"Yasukawa, H. et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309\u20131320 (1999).","journal-title":"EMBO J."},{"key":"BFni1012_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/proeng\/gzg015","volume":"16","author":"F Giordanetto","year":"2003","unstructured":"Giordanetto, F. & Kroemer, R.T. A three-dimensional model of suppressor of cytokine signalling 1 (SOCS-1). Protein Eng. 16, 115\u2013124 (2003).","journal-title":"Protein Eng."},{"key":"BFni1012_CR19","doi-asserted-by":"publisher","first-page":"29338","DOI":"10.1074\/jbc.M003456200","volume":"275","author":"A Sasaki","year":"2000","unstructured":"Sasaki, A. et al. CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 275, 29338\u201329347 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR20","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1073\/pnas.100135197","volume":"97","author":"SE Nicholson","year":"2000","unstructured":"Nicholson, S.E. et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl Acad. Sci. USA 97, 6493\u20136498 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni1012_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1074\/jbc.M210552200","volume":"278","author":"U Lehmann","year":"2003","unstructured":"Lehmann, U. et al. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J. Biol. Chem. 278, 661\u2013671 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR22","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1046\/j.1432-1033.2002.02916.x","volume":"269","author":"M Hortner","year":"2002","unstructured":"Hortner, M., Nielsch, U., Mayr, L.M., Heinrich, P.C. & Haan, S. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur. J. Biochem. 269, 2516\u20132526 (2002).","journal-title":"Eur. J. Biochem."},{"key":"BFni1012_CR23","doi-asserted-by":"publisher","first-page":"40649","DOI":"10.1074\/jbc.M007577200","volume":"275","author":"C Bjorbaek","year":"2000","unstructured":"Bjorbaek, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649\u201340657 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR24","doi-asserted-by":"publisher","first-page":"9229","DOI":"10.1021\/bi0259507","volume":"41","author":"D De Souza","year":"2002","unstructured":"De Souza, D. et al. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 41, 9229\u20139236 (2002).","journal-title":"Biochemistry"},{"key":"BFni1012_CR25","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1101\/gad.12.24.3872","volume":"12","author":"T Kamura","year":"1998","unstructured":"Kamura, T. et al. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat and ankyrin repeat families. Genes Dev. 12, 3872\u20133881 (1998).","journal-title":"Genes Dev."},{"key":"BFni1012_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","volume":"96","author":"JG Zhang","year":"1999","unstructured":"Zhang, J.G. et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071\u20132076 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR27","doi-asserted-by":"publisher","first-page":"12530","DOI":"10.1074\/jbc.M010074200","volume":"276","author":"S Kamizono","year":"2001","unstructured":"Kamizono, S. et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276, 12530\u201312538 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR28","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1128\/MCB.21.10.3547-3557.2001","volume":"21","author":"J Frantsve","year":"2001","unstructured":"Frantsve, J., Schwaller, J., Sternberg, D.W., Kutok, J. & Gilliland, D.G. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21, 3547\u20133557 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFni1012_CR29","doi-asserted-by":"publisher","first-page":"13261","DOI":"10.1073\/pnas.231486498","volume":"98","author":"JG Zhang","year":"2001","unstructured":"Zhang, J.G. et al. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98, 13261\u201313265 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR30","doi-asserted-by":"publisher","first-page":"31972","DOI":"10.1074\/jbc.M303170200","volume":"278","author":"S Haan","year":"2003","unstructured":"Haan, S. et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278, 31972\u201331979 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR31","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.1073\/pnas.95.26.15577","volume":"95","author":"T Naka","year":"1998","unstructured":"Naka, T. et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1)-deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577\u201315582 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR32","doi-asserted-by":"publisher","first-page":"14395","DOI":"10.1073\/pnas.95.24.14395","volume":"95","author":"R Starr","year":"1998","unstructured":"Starr, R. et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395\u201314399 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0092-8674(00)80048-3","volume":"98","author":"JC Marine","year":"1999","unstructured":"Marine, J.C. et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609\u2013616 (1999).","journal-title":"Cell"},{"key":"BFni1012_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","volume":"98","author":"WS Alexander","year":"1999","unstructured":"Alexander, W.S. et al. SOCS1 is a critical inhibitor of interferon-signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597\u2013608 (1999).","journal-title":"Cell"},{"key":"BFni1012_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1046\/j.1365-2567.2001.01294.x","volume":"104","author":"DV Bullen","year":"2001","unstructured":"Bullen, D.V., Darwiche, R., Metcalf, D., Handman, E. & Alexander, W.S. Neutralization of interferon- in neonatal SOCS1\u2212\/\u2212 mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology 104, 92\u201398 (2001).","journal-title":"Immunology"},{"key":"BFni1012_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1073\/pnas.022628499","volume":"99","author":"D Metcalf","year":"2002","unstructured":"Metcalf, D. et al. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc. Natl. Acad. Sci. USA 99, 943\u2013948 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1074-7613(03)00240-1","volume":"19","author":"T Hanada","year":"2003","unstructured":"Hanada, T. et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19, 437\u2013450 (2003).","journal-title":"Immunity"},{"key":"BFni1012_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood.V97.1.221","volume":"97","author":"B Sporri","year":"2001","unstructured":"Sporri, B., Kovanen, P.E., Sasaki, A., Yoshimura, A. & Leonard, W.J. JAB\/SOCS1\/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97, 221\u2013226 (2001).","journal-title":"Blood"},{"key":"BFni1012_CR39","doi-asserted-by":"publisher","first-page":"22755","DOI":"10.1074\/jbc.M303021200","volume":"278","author":"AL Cornish","year":"2003","unstructured":"Cornish, A.L. et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other \u03b3 c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278, 22755\u201322761 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1074-7613(00)00078-9","volume":"13","author":"S Diehl","year":"2000","unstructured":"Diehl, S. et al. Inhibition of TH1 differentiation by IL-6 is mediated by SOCS1. Immunity 13, 805\u2013815 (2000).","journal-title":"Immunity"},{"key":"BFni1012_CR41","doi-asserted-by":"publisher","first-page":"43735","DOI":"10.1074\/jbc.M208586200","volume":"277","author":"JL Eyles","year":"2002","unstructured":"Eyles, J.L., Metcalf, D., Grusby, M.J., Hilton, D.J. & Starr, R. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1. J. Biol. Chem. 277, 43735\u201343740 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFni1012_CR42","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.4049\/jimmunol.171.5.2435","volume":"171","author":"S Ilangumaran","year":"2003","unstructured":"Ilangumaran, S., Ramanathan, S., La Rose, J., Poussier, P. & Rottapel, R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. J. Immunol. 171, 2435\u20132445 (2003).","journal-title":"J. Immunol."},{"key":"BFni1012_CR43","unstructured":"Ilangumaran, S. et al. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. Blood prepublished online, 7 August 2003 (doi:10.1182\/blood-2003-01-0175)."},{"key":"BFni1012_CR44","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1073\/pnas.090084797","volume":"97","author":"Y Morita","year":"2000","unstructured":"Morita, Y. et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)\/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor-necrosis-factor\u2014induced cell death in fibroblasts. Proc. Natl. Acad. Sci. USA 97, 5405\u20135410 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1074-7613(02)00446-6","volume":"17","author":"I Kinjyo","year":"2002","unstructured":"Kinjyo, I. et al. SOCS1\/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583\u2013591 (2002).","journal-title":"Immunity"},{"key":"BFni1012_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1074-7613(02)00449-1","volume":"17","author":"R Nakagawa","year":"2002","unstructured":"Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677\u2013687 (2002).","journal-title":"Immunity"},{"key":"BFni1012_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1084\/jem.193.2.263","volume":"193","author":"Y Kawazoe","year":"2001","unstructured":"Kawazoe, Y. et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)\/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193, 263\u2013269 (2001).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/emboj\/18.4.904","volume":"18","author":"P De Sepulveda","year":"1999","unstructured":"De Sepulveda, P. et al. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18, 904\u2013915 (1999).","journal-title":"EMBO J."},{"key":"BFni1012_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1074-7613(01)00132-7","volume":"14","author":"T Naka","year":"2001","unstructured":"Naka, T. et al. SOCS-1\/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN- and IL-4 signaling in vivo. Immunity 14, 535\u2013545 (2001).","journal-title":"Immunity"},{"key":"BFni1012_CR50","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.1073\/pnas.1032925100","volume":"100","author":"D Metcalf","year":"2003","unstructured":"Metcalf, D., Mifsud, S., Di Rago, L. & Alexander, W.S. The lethal effects of transplantation of Socs1\u2212\/\u2212 bone marrow cells into irradiated adult syngeneic recipients Proc. Natl. Acad. Sci. USA 100, 8436\u20138441 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1074-7613(03)00078-5","volume":"18","author":"MM Chong","year":"2003","unstructured":"Chong, M.M. et al. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 18, 475\u2013487 (2003).","journal-title":"Immunity"},{"key":"BFni1012_CR52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.4049\/jimmunol.170.2.878","volume":"170","author":"AL Cornish","year":"2003","unstructured":"Cornish, A.L. et al. Suppressor of cytokine signaling-1 has IFN-independent actions in T cell homeostasis J. Immunol. 170, 878\u2013886 (2003).","journal-title":"J. Immunol."},{"key":"BFni1012_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.173.1.89","volume":"173","author":"DB Lewis","year":"1991","unstructured":"Lewis, D.B. et al. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173, 89\u2013100 (1991).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","volume":"16","author":"RS McHugh","year":"2002","unstructured":"McHugh, R.S. et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311\u2013323 (2002).","journal-title":"Immunity"},{"key":"BFni1012_CR55","unstructured":"Naka, T. et al. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. (in the press)."},{"key":"BFni1012_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.1078231","volume":"299","author":"C Pasare","year":"2003","unstructured":"Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033\u20131036 (2003).","journal-title":"Science"},{"key":"BFni1012_CR57","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/intimm\/dxf094","volume":"14","author":"M Fujimoto","year":"2002","unstructured":"Fujimoto, M. et al. A regulatory role for suppressor of cytokine signaling-1 in Th polarization in vivo. Int. Immunol. 14, 1343\u20131350 (2002).","journal-title":"Int. Immunol."},{"key":"BFni1012_CR58","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1172\/JCI16156","volume":"111","author":"PJ Egan","year":"2003","unstructured":"Egan, P.J., Lawlor, K.E., Alexander, W.S. & Wicks, I.P. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 111, 915\u2013924 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFni1012_CR59","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.4049\/jimmunol.168.7.3181","volume":"168","author":"CE Egwuagu","year":"2002","unstructured":"Egwuagu, C.E. et al. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168, 3181\u20133187 (2002).","journal-title":"J. Immunol."},{"key":"BFni1012_CR60","doi-asserted-by":"publisher","first-page":"9324","DOI":"10.1073\/pnas.161271798","volume":"98","author":"AW Roberts","year":"2003","unstructured":"Roberts, A.W. et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc. Natl. Acad. Sci. USA 98, 9324\u20139329 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1012_CR61","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/emboj\/cdg057","volume":"22","author":"Y Takahashi","year":"2003","unstructured":"Takahashi, Y. et al. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 22, 372\u2013384 (2003).","journal-title":"EMBO J."},{"key":"BFni1012_CR62","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm896","volume":"9","author":"Y Seki","year":"2003","unstructured":"Seki, Y. et al. SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses Nat. Med. 9, 1047\u20131054 (2003).","journal-title":"Nat. Med."},{"key":"BFni1012_CR63","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1128\/MCB.19.7.4980","volume":"19","author":"SJ Cohney","year":"1999","unstructured":"Cohney, S.J. et al. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell Biol. 19, 4980\u20134988 (1999).","journal-title":"Mol. Cell Biol."},{"key":"BFni1012_CR64","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.4049\/jimmunol.168.9.4277","volume":"168","author":"A Banerjee","year":"2002","unstructured":"Banerjee, A., Banks, A.S., Nawijn, M.C., Chen, X.P. & Rothman, P.B. Cutting edge: Suppressor of cytokine signaling 3 inhibits activation of NFATp. J. Immunol. 168, 4277\u20134281 (2002).","journal-title":"J. Immunol."},{"key":"BFni1012_CR65","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1084\/jem.20020939","volume":"197","author":"A Matsumoto","year":"2003","unstructured":"Matsumoto, A. et al. A role of suppressor of cytokine signaling 3 (SOCS3\/CIS3\/SSI3) in CD28-mediated interleukin 2 production. J. Exp. Med. 197, 425\u2013436 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1042\/bj3490099","volume":"349","author":"A Crepso","year":"2000","unstructured":"Crepso, A., Filla, M.B., Russell, S.W. & Murphy, W.J. Indirect induction of suppressor of cytokine signaling-1 in macrophages stimulated with bacterial lipopolysaccharide: partial role of autocrine\/paracrine interferon-\u03b1\/\u03b2. Biochem. J. 349, 99\u2013104 (2000).","journal-title":"Biochem. J."},{"key":"BFni1012_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0014-5793(99)01662-2","volume":"463","author":"JG Bode","year":"1999","unstructured":"Bode, J.G. et al. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. LPS and TNF\u03b1 induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 463, 365\u2013370 (1999).","journal-title":"FEBS Lett."},{"key":"BFni1012_CR68","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.4049\/jimmunol.166.12.7082","volume":"166","author":"AH Dalpke","year":"2001","unstructured":"Dalpke, A.H., Opper, S., Zimmermann, S. & Heeg, K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166, 7082\u20137089 (2001).","journal-title":"J. Immunol."},{"key":"BFni1012_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1074-7613(00)80005-9","volume":"10","author":"K Takeda","year":"1999","unstructured":"Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39\u201349 (1999).","journal-title":"Immunity"},{"key":"BFni1012_CR70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni938","volume":"4","author":"H Yasukawa","year":"2003","unstructured":"Yasukawa, H. et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551\u2013556 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1012_CR71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1074-7613(03)00232-2","volume":"19","author":"F Cheng","year":"2003","unstructured":"Cheng, F. et al. A critical role for Stat3 signaling in immune tolerance. Immunity 19, 425\u2013436 (2003).","journal-title":"Immunity"},{"key":"BFni1012_CR72","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ni932","volume":"4","author":"R Lang","year":"2003","unstructured":"Lang, R. et al. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546\u2013550 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1012_CR73","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ni931","volume":"4","author":"BA Croker","year":"2003","unstructured":"Croker, B.A. et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540\u2013555 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1012_CR74","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/10799900260475669","volume":"22","author":"SA Brod","year":"2002","unstructured":"Brod, S.A. Ingested type I interferon: a potential treatment for autoimmunity. J. Interferon Cytokine Res. 22, 1153\u201311566 (2002).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFni1012_CR75","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20020619","volume":"196","author":"T Atsumi","year":"2002","unstructured":"Atsumi, T. et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 196, 979\u2013990 (2002).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR76","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/nm763","volume":"8","author":"NC Tebbutt","year":"2002","unstructured":"Tebbutt, N.C. et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8, 1089\u20131097 (2002).","journal-title":"Nat. Med."},{"key":"BFni1012_CR77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1084\/jem.193.4.471","volume":"193","author":"A Suzuki","year":"2001","unstructured":"Suzuki, A. et al. CIS3\/SOCS3\/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193, 471\u2013481 (2001).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR78","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1172\/JCI13568","volume":"108","author":"T Shouda","year":"2001","unstructured":"Shouda, T. et al. Induction of the cytokine signal regulator SOCS3\/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108, 1781\u20131788 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFni1012_CR79","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1128\/MCB.19.9.6396","volume":"19","author":"A Matsumoto","year":"1999","unstructured":"Matsumoto, A. et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell Biol. 19, 6396\u20136407 (1999).","journal-title":"Mol. Cell Biol."},{"key":"BFni1012_CR80","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1084\/jem.191.6.985","volume":"191","author":"S Li","year":"2000","unstructured":"Li, S. et al. Cytokine-induced Src-homology 2 protein (CIS) promotes T-cell receptor-mediated proliferation and prolongs survival of activated T cells. J. Exp. Med. 191, 985\u2013994 (2000).","journal-title":"J. Exp. Med."},{"key":"BFni1012_CR81","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1128\/MCB.22.13.4567-4578.2002","volume":"22","author":"DL Krebs","year":"2002","unstructured":"Krebs, D.L. et al. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell Biol. 22, 4567\u20134578 (2002).","journal-title":"Mol. Cell Biol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni1012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1012","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:36:27Z","timestamp":1684449387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni1012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,24]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BFni1012"],"URL":"https:\/\/doi.org\/10.1038\/ni1012","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,24]]}}}